Cardiology Flashcards
Pathology of AF
Left atrium loses its refractoriness before end of atrial systole
Gives recurrent uncoordinated contraction 300bpm
atrial contraction is responsible for around 25% CO thus it often triggers HF.
Causes of AF
Common IHD Rheumatic heart disease Thyrotoxicosis Hypertension
Other Alcohol Pneumonia PE Post-op Hypokalaemia RA
Symptoms AF
Symptoms Asympto Chest pain Palpitations Dyspnoea Faintnes
Signs AF
Signs
Irregularly irregular pulse
Pulse deficit: difference between pulse and HS
Fast AF → loss of diastolic filling → no palpable pulse
Signs of LVF
Investigations AF
- ECG
FBC, U+E, TFTs, Trop
Consider TTE: structural abnormalities
Management acute AF
haemodynamically unstable –
1st line – emergency cardioversion
2nd line – IV amiodarone
control ventricular rate:
1st line – diltiazem/verapamil/metoprolol
2nd line – digoxin or amiodarone
start LMWH
Cardioversion in AF
only done in acute causes <48 hours
electrical or pharmacological
Pharm:
1st line – flecainide if no structural heart disease
2nd line – amiodarone IV
Flecainide MOA
sodium channel blocker
slows upstroke of cardiac action potential
Paroxysmal AF
a self limiting flare up of AF lasting less than 7 days with recurrence tendency
use CHADSVASC to decide to anticoagulate
Treatment with pill in pocket
(flecainide) to manage flare up
Prevention
- B blocker
- Sotalol
- amiodarone
What is persistent AF
AF lasting > 7 days
may recur even after cardioversion
How to treat persistent AF
Try rhythm control if:
- symptomatic
- age< 65
- first incidence
What is rhythm control treatment AF
Rhythm Control (cardioversion) need to follow these steps as it is a risky treatment
TTE first: look for structural abnormalities
Anticoagulate ̄c warfarin for ≥3wks
or use TOE to exclude intracardiac thrombus.
Pre-Rx ≥4wks ̄c sotalol or amiodarone if ↑ risk of failure
Electrical or pharmacological cardioversion eg flecainide (this is the treatment step)
≥ 4 wks anticoagulation afterwards (target INR 2.5)
AF maintenance antiarrhythmic
Not needed if successfully treated precipitant
1st line — B blocker
2nd line – amiodarone
Final options for AF treatment
radiofrequency ablation of AV node
Maze procedure create scar tissue
Pacing
Rate control for AF
This is used when can’t do rhythm control
Target HR <90
1st line – B blocker or rate limiting CCB (not together)
2nd line – add digoxin
3rd line – Consider amiodarone
When to use rate control in AF
failed cardioversion
patient doesn’t want cardioversion
AF>1 year/ valve disease/ poor LV function
Management of atrial flutter
manage as for AF
drugs may not work
amiodarone to restore sinus
amiodarone to maintain sinus
cavotricuspid isthmus ablation right atrium is treatment of choice.
CHA2DS2VAS score
determines necessity of anticoagulation in AF
CCF HTN AGE >75 (2 points) Diabetes Stroke or TIA (2 points) Vascular disease Age 65-74 Sex female
Score
1- aspirin 300mg
2+ - warfarin
Acute coronary syndrome definition
unstable angina + evolving MI
ST elevation or new onset LBB
NSTEMI
Pathophysiology of ACS
plaque rupture
thrombosis
inflammation
Symptoms ACS
acute central chest pain < 20mins radiates to left arm/jaw nausea sweating dyspnoea palpitations
Signs of ACS
anxiety pallor sweating pulse up then down BP up then down 4th heart sound signs of LVF - basal crepitations, raised JVP, 3rd HS
DDX of ACS
angina peri/endo/myo carditits dissection PE, pneumothorax, pneumonia costochondritis GORD anxiety
Investigations ACS
ECG Bloods - troponin - FBC -U&E - glucose -lipids -INR CXR
STEMI ECG
STEMI Sequence Normal ST elevation + hyperacute (tall) T waves Q waves: full-thickness infarct Normalisation of ST segments T wave inversion (New onset LBBB also = STEMI)
NSTEMI ECG
ST depression
T wave inversion
Subendocardial infarct ECG
No Q waves
Inferior MI ECG
2
3
avf
vessel RCA
anterolateral MI ECG
1
avl
V4-V6
vessel LCx
Anteroseptal MI ECG
V2-V4
vessel LAD
Anterior MI ECG
V2-V6
vessel LMCA
Posterior MI ECG
V1-V3 reciprocal changes
vessel RCA
ACS blood results
Troponin T and I
look at 3 and 12 hours
peak 24 hours returns to baseline 5-14 days
CXR ACS
cardiomegaly
pulmonary oedema
widened mediastinum - aortic rupture
ACS diagnosis
STEMI/LBB
- typical symptoms + ST elevation / LBB
NSTEMI
- typical symptoms + no ST elevation + +ve troponin
UA
- typical symptoms + no ST elevation + -ve troponin
STEMI treatment brief
PCI or thrombolysis
NSTEMI/UA treatment brief
medical + elective angioplasty +- PCI/CABG
MI complications
Death Passing PRAED st.
Death- VF, LVF, CVA
Pump failure
Pericarditis - mild fever pericardial friction rub relieved by sitting forward, ECG saddle shaped ST elevation, give ibuprofen
Rupture - myomalacia cordis, cardiac tamponade giving beck’s triad (drop BP, rise JVP, muffled heart sounds) and pulsus paradoxus. Papillary muscle = Mitral regurg. septum = heart failure
Arrhythmias
Aneurysm- ventricular
Embolism from LV mural thrombus
Dressler’s syndrome - autoantibodies against myocyte sarcolemma
read through notes following this flashcard more info
Pulsus paradoxus
drop in systolic BP >10mmHg on inspiration
STEMI management
MONAC Morphine- 5-10mg IV Metoclopramide - 10mg IV Oxygen - 2-4L sats 94-98% Nitroglycerin - 2 puffs Aspirin 300mg PO then 75mg/day Clopidogrel - 300mg po then 75mg/day
12 lead ECG
LMWH eg enoxaparin IV then subcut
Admit to CCU
Primary PCI or thrombolysis
Choosing PCI or thrombolysis
PCI if <12 hours
Thrombolysis if >24 hours from pain onset
If not suitable for either then give fondaparinux
What does PCI involve
angioplasty and stenting
+ GP IIA/IIIA antagonist eg clopidogrel, tirofiban
- give this if patient is delayed PCI, diabetes, complex
Complications of PCI
bleeding
emboli
arrhythmia
ECG criteria for thrombolysis
ST elevation >1mm in 2+ limb leads or >2mm in 2+ chest leads
New LBBB
Posterior MI - DEEP ST depression in V1-V3 and tall R waves
Contraindications for thrombolysis
AGAINST
Aortic dissection GI bleeding Allergic reaction previously Iatrogenic- recent surgery Neuro- cerebral neoplasm Severe HTN Trauma - including CPR
Thrombolysis drugs
Alteplase (tissue plasminogen activator )
streptokinase
tenecteplase
Complications thrombolysis
bleeding
stroke
arrhythmia
allergic reaction
Continuing therapy post MI
ACEi- start within 24 hours
B blocker
Aspirin (+- clopidogrel)
statin
and cardiac rehabilitation programme
lifestyle advice
lifestyle advice post MI
stop smoking diet- oily fish, decrease sat fats exercise 30min/day work== return in 2 months sex == avoid 1 month driving== avoid 1 month
NSTEMI and UA management
MONAC
fondaparinux
12 lead ECG
GRACE score
High risk - persistent recurrent ischaemia, ST depression, DM, positive troponin
Low risk- No pain , flat or inverted T waves, normal ECG, negative troponin
GRACE score
used to assess ACS risk
Managing high risk GRACE UA NSTEMI
GP2a/3a antagonist- tirofiban
angiography +- PCI within 96 hours
clopidogrel 75mg/day for one year
Managing low risk GRACE UA NSTEMI
may discharge after 12 hours if troponin negative
follow up outpatient tests
- angiography
- perfusion scan
- stress echo
Angina pectoris pathophysiology
atherosclerosis leading to ischaemia
Causes of angina
mostly atheroma anaemia aortic stenosis tachyarrhythmias arteritits
Symptoms angina pectoris
central chest tightness
brought on by exertion and relieved by rest
may radiate to arms/jaw
precipitants - emotion, cold weather, heavy meals
Classification of Angina
Stable - induced by effort
Unstable - occurs at rest, minimal exertion
Decubitus - induced by lying down
Variant - at rest due to coronary spasm, gives ST elevation during attack, treat with CCB and long acting nitrate
Syndrome X - angina pain and ST elevation on exercise test no evidence of coronary atherosclerosis
DDX angina
Aortic stenosis
Aortic aneurysm
GORD
chostrochondritis
Investigations angina
Angiography (gold standard) Bloods - FBC UE lipids glucose ESR TFTs ECG - usually normal Exercise ECG Stress echo Perfusion scan CT coronary calcium score
Management of angina pectoris overview
Lifestyle
Medical
Interventional
Surgical
Medical management angina
secondary prevention
- aspirin
- ACEi
- Statin
- Antihypertensive
Anti anginals - GTN spray/sublingual \+ B blocker \+ CCB \+ Both (Amlodipine)
+ ivabradine
+nicorandil
Interventional management of angina pectoris
What
-PCI
When
- poor response to medical treatment
- not suitable for CABG
Complications
- restenosis
- MI
- Death
clopidogrel reduces risk of restenosis best to use drug eluting stent as well
Surgical management of Angina
What
- CABG
When
- LMCA disease
- Triple vessel disease
- Refractory angina
- Unsuccessful PCI
Complications
- stroke
- MI
- Pericardial tamponade
- Post perfusion syndrome
- Post op AF
- Graft stenosis
Heart failure definition
CO is inadequate for the body’s requirements despite adequate filling pressures
Pathophysiology of Heart failure
Initial reduction in CO== compensation starling effect dilates heart to enhance contractility remodelling == hypertrophy RAAS activation ANP/BNP release Sympathetic activation
Progressive decline in CO == decompensation
progressive dilation gives impaired contractility and valve regurgitation
hypertrophy leads to relative myocardial ischaemia
RAAS activation leads to Na+ retention and fluid retention == increased venous pressure and oedema
sympathetic excess - increased afterload and decreased CO
Causes of low output cardiac failure
Low output cardiac failure is when CO drops and it can’t increase with exertion
1. Pump failure: Systolic failure → impaired contraction Ischaemia/MI (commonest cause) Dilated cardiomyopathy Hypertension Myocarditis
Diastolic failure → impaired filling
Pericardial effusion / tamponade / constriction
Cardiomyopathy: restrictive, hypertrophic
Arrhythmias
Bradycardia, heart block
Tachycardias
Anti-arrhythmics (e.g. beta-blocker, verapamil)
2. Excessive pre-load AR,MR Fluid overload t 3. Excessive afterload AS HTN HOCM hypertrophic cardiomyopathy
Causes of high output cardiac failure
This is when body has increased needs which the heart can’t meet, initially gives RVF then LVF.
Anaemia, Arteriovenous malformation
Thyrotoxicosis, Thiamine deficiency (beri Beri)
Pregnancy, Pagets
What are the causes, symptoms and signs of RVF
Causes:
- LVF
- Cor pulmonale
- Tricuspid and pulmonary valve disease
Symptoms:
- Anorexia
- Nausea
Signs: ↑JVP + jugular venous distension Tender smooth hepatomegaly (may be pulsatile) Pitting oedema Ascites
LVF causes symptoms and signs
Causes 1st: IHD 2nd: idiopathic dilated cardiomyopathy 3rd: Systemic HTN 4th: Mitral and aortic valve disease Specific cardiomyopathies
Symptoms
Fatigue
Exertional dyspnoea
Orthopnoea + PND paroxysmal nocturnal dyspnoea
Nocturnal cough (± pink, frothy sputum)
Wt. loss and muscle wasting
Signs Cold peripheries ± cyanosis Often in AF Cardiomegaly ̄c displaced apex S3 + tachycardia = gallop rhythm Wheeze (cardiac asthma) Bibasal creps
Chronic HF FRAMINGHAM Criteria
For CCF diagnosis need 2 major
or 1 major + 2 minor
Major:
- Paroxysmal nocturnal dyspnoea
- Neck vein distension
- Cardiomegaly
- Acute pulmonary oedema
- Increase CVP
CCF Investigations
Bloods- FBC UE BNP TFTs glucose lipids
CXR - ABCDE (Alveolar shadowing bats wings, B kerley lines, Cardiomegaly, Dilated upper veins, Effusions)
ECG- Ischaemia, hypertrophy, AF
Echocardiogram - Hypertrophy, valve lesions, Intracardiac shunts, Reduced ejection fraction, hypokinesia
BNP actions and use as a marker
Actions:
↑ GFR and ↓ renal Na reabsorption
↓ preload by relaxing smooth muscle
Marker:
↑ BNP (>100) better than any other variable and
clinical judgement in diagnosing heart failure
BNP correlates ̄c LV dysfunction
i.e. ↑ most in decompensated heart failure
↑ BNP = ↑ mortality
BNP <100 excludes heart failure (96% NPV)
BNP also ↑ in RHF: cor pulmonale, PE
New York Heart Association Classification
- No limitation of activity
- Comfortable @ rest, dyspnoea on ordinary activity
- Marked limitation of ordinary activity
- Dyspnoea @ rest, all activity → discomfort
CCF specific management
1st line:
ACEi/ARB + B Blocker + Loop Diuretic
with B blockers start low and go slow
2nd line:
K+ saving diuretic - spironolactone
(watch for hyperkalaemia especially if on ACEi as well)
ACEi + ARB
Vasodilators (hydralazine + ISDN)
3rd line:
Digoxin
ICD
Things to monitor in chronic CCF
BP may be very low
Renal function
Plasma K if on spironolactone and ACEi
Daily weight
Management severe pulmonary oedema
- Sit patient up
- Oxygen 15L non rebreath mask target 94-98%
- IV access and monitor ECG (bloods and treat any arrhythmias
- Diamorphine 2.5-5mg IV (pain and is pulmonary venodilator) + metoclopramide 10mg IV
- Furosemide 40-80mg IV
- GTN 2 puffs or 2 buccal tablets (unless SBP<90)
- If SBP>100 start nitrate infusion
- if worsening consider CPAP dialysis
If SBP drops below 100 treat as cardiogenic shock and give inotropes
Causes severe pulmonary oedema cardiac and non cardiac
Cardiogenic
MI
Arrhythmia
Fluid overload: renal, iatrogenic
Non-cardiogenic
ARDS: sepsis, post-op, trauma
Upper airway obstruction
Neurogenic: head injury
Pulmonary oedema symptoms
Dyspnoea
Orthopnoea
pink frothy sputum
Pulmonary oedema signs
Distressed, sweaty, cyanosed Tachycardia Tachypnoea Raised JVP S3 gallop rhythm Bibasal crepitations Pleural effusions Wheeze
Pulmonary oedema DDx
Asthma
COPD
Pneumonia
PE
Cardiogenic shock definition
decreased cardiac output and evidence of tissue hypoxia in the presence of adequate intravascular volume.
the failure of CO is due to pump failure
Management cardiogenic shock
- Oxygen 15L nonrebreath mask 94-98%
- IV access and monitor ECG
- Diamorphine 2.5-5mg IV + metoclopramide
- Correct any arrhythmias, electrolyte disturbances, acid-base abnormalities
- CXR, Echo, CT thorax
- Monitor CVP, BP, ABG, ECG, Urine
- Consider need for inotropes dobutamine
- Treat underlying cause
Causes of cardiogenic shock
MI HEART
MI Hyperkalaemia (inc. electrolytes) Endocarditis (valve destruction) Aortic Dissection Rhythm disturbance Tamponade
+ obstructive causes
- Tension pneumothorax
- Massive PE
Presentation of cardiogenic shock
Unwell, pale, sweaty, cyanosed, distressed
cold clammy peripheries,
↑RR ± ↑HR
Pulmonary oedema
Cardiac tamponade causes
Trauma Lung/breast Ca Pericarditis MI Bacteria (e.g. TB)
Cardiac tamponade signs
Beck’s triad: ↓BP, ↑JVP, muffled heart sounds
Kussmaul’s sign: ↑JVP on inspiration
Pulsus paradoxus (pulse fades on inspiration)
Cardiac tamponade investigations
Echo - diagnostic
CXR - globular heart
Cardiac tamponade Management
ABCDE
Pericardiocentesis using echo guidance is best
Hypertension definitions stages
Stage 1: Clinic BP > 140/90 Stage 2: Clinic BP > 160/100 Severe: Clinic BP > 180/110 Malignant: BP > 180/110 + papilloedema and/or retinal haemorrhage Isolated SHT: SBP ≥140, DBP <90